The development of COVID-19 vaccines and treatments over the past year has been nothing less than a triumph of innovation. The unprecedented speed with which researchers and life sciences companies have met this challenge is astounding. Unfortunately, at every step on this path, some have sought to undermine the intellectual property rights that have underpinned this effort.
It’s difficult to achieve innovation without the protection of ideas, and as a growing share of global economic value creation and exchange has become knowledge-based, intellectual property rights and protections have become an increasingly important facet of global trade. This category includes all GTIPA-member reports addressing trade and IP issues.